logo
Plus   Neg
Share
Email

Pfizer : Bavencio Improves OS In Patients With Metastatic Urothelial Carcinoma

EMD Serono, the biopharmaceutical business of Merck KgaA (MKGAY.PK), and Pfizer Inc. (PFE) said that Bavencio significantly improved overall survival in patients with locally advanced or metastatic urothelial carcinoma. The late-stage JAVELIN Bladder 100 study met its primary endpoint of overall survival at the planned interim analysis.

In this study, patients with previously untreated locally advanced or metastatic urothelial carcinoma whose disease did not progress on induction chemotherapy and who were randomized to receive first-line maintenance therapy with BAVENCIO and best supportive care lived significantly longer than those who received best supportive care only.

In November 2014, Merck KGaA, Darmstadt, Germany and Pfizer announced a strategic alliance to co-develop and co-commercialize BAVENCIO. BAVENCIO is a human anti-programmed death ligand-1 (PD-L1) antibody.

Bladder cancer is the tenth most common cancer worldwide. In 2018, there were over half a million new cases of bladder cancer diagnosed, with around 200,000 deaths from the disease globally. Urothelial carcinoma accounts for about 90% of all bladder cancers.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Deutsche Telekom AG were gaining around 4 percent in the morning trading after the German telecom giant reported Wednesday a profit in its fourth quarter, compared to last year's loss. The company also projects higher results in fiscal 2020. For the new year, Deutsche Telekom expects another increase in revenue from fiscal 2019 revenue of 80.5 billion euros. Boeing Co., which is struggling to relaunch its grounded 737 MAX jets to service, has been hit with a new potential safety concern. The planemaker found debris in the fuel tanks of several undelivered 737 MAX jetliners, multiple reports said citing an internal memo. The Foreign Object Debris were found during maintenance work on an undisclosed number of jets parked at various facilities. Tesla has been ordered to stop work at the site of its proposed $4-billion Gigafactory in the German state of Brandenburg due to environmental concerns, according to reports. The proposed factory was going to be Tesla's first Gigafactory in Europe and its fourth in the world. On Saturday, a German court reportedly ordered the company to stop cutting down trees on the 300-hectare site.
Follow RTT
>